When administering Heparin, key nursing considerations include monitoring patient status, checking critical laboratory values, and providing appropriate safety education. Unsafe practices such as stopping medications abruptly or doubling missed doses are incorrect.
In-depth explanation
Clinical reasoning summary
Apixaban — patient teaching
Apixaban is a direct factor Xa inhibitor used for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of VTE.
Key teaching:
• 5 mg PO twice daily approximately 12 hours apart; reduce to 2.5 mg BID if any 2 of: age ≥80, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL.
• Take with or without food; do NOT crush or split unless using the pre-approved crushed-administration option (apixaban CAN be crushed and dispersed in water/apple juice for NG tube — different from dabigatran).
• No routine coagulation monitoring — apixaban does NOT prolong INR predictably, so INR is not used. Anti-Xa specific to apixaban can confirm presence in select cases.
• Drug interactions: avoid concurrent strong CYP3A4 / P-gp inhibitors (ketoconazole, ritonavir) — increase bleeding; strong inducers (rifampin, phenytoin, carbamazepine, St. Johns wort) reduce effect.
• Bleeding precautions: soft toothbrush, electric razor, fall prevention, avoid IM injections, avoid NSAIDs/aspirin without provider, report any bruising/dark stool/pink urine/persistent headache/fall.
• Do NOT self-discontinue: even when rhythm feels normal, afib stroke risk persists; abrupt cessation increases stroke risk significantly.
• Surgery: hold 24–48 hours pre-op (low risk) or 48 hours+ (high risk) per provider; resume per surgeon.
• Reversal: andexanet alfa for major bleeding; PCC alternative if andexanet unavailable.
For study reference only. Always follow current clinical guidelines and your institution’s protocols.